Isil Yazici Gencdal

Isil Yazici Gencdal

Auto-generated profile, based on publicly available information

Isil Yazici Gencdal

Division of Clinical Neurophysiology, Department of Neurology, Faculty of Medicine, İstanbul University, İstanbul, Turkiye

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2020 in Turkish Journal of Gastroenterology
Verified
Journal Article
Closed access
GGGenco Gencdal
Genco Gencdal
GTGamze Türker
Gamze Türker
IGIşıl Yazıcı Gençdal
Işıl Yazıcı Gençdal
BEBurçak Ekinci
Burçak Ekinci
SENCAN ACARSENCAN ACAR
SENCAN ACAR
MAMurat Akyıldız
Murat Akyıldız
Background/Aims: Sleep disorders (SDs) are frequently seen in cirrhotics. Polysomnography (PSG), actigraphy and electroencephalogram (EEG) are common objective methods to diagnose SDs. The most commonly used subjective methods are the Pittsburgh Sleep Quality Index (PSQI) and Epworth sleepiness scale (ESS). In this study, we aimed to evaluate the effect of liver transplantation on SDs by using a combination of objective (PSG and EEG) and subjective methods (PSQI and ESS). Material and Methods: Eighteen cirrhotic patients on a liver transplantation (LTx) waiting list were included in the study. Patient clinical status, biochemical parameters were evaluated. All patients completed validated Turkish forms of the PSQI and ESS before and nine-months after LTx. All patients underwent EEG and PSG before and nine-months after LTx. Results: Eighteen patients with liver cirrhosis (male: 12; 66.7%, mean age: 53.22±10.43 years) were included in the study. Pre-transplant and nine-month post-transplant mean PSQI and ESS scores were 8.4±3.11 and 7.28±3.89; 4.5±2.8 and 4.72±2.91 (p<0.01), respectively. Pre-transplantation, metabolic encephalopathy was detected in 6 of 18 patients by EEG, while metabolic encephalopathy was detected in only one patient post-transplant. Post-transplantation PSG sleep duration (all stages) increased relative to pre-transplant PSG values. Sleep latency (SL) and REM (Rapid eye movement) latency were found to be reduced relative to pre-transplant values. Conclusion: This was a pilot study comparing SDs in pre- and post-liver transplant patients by combining subjective and objective methods. Significant SD improvements were found at the ninth month.

5 March 2025 in Neurological Research
Verified
Journal Article
Closed access
IGIsil Yazıcı Gencdal
Isil Yazıcı Gencdal
NSNermin Gorkem Sirin
Nermin Gorkem Sirin
TATugrul Artug
Tugrul Artug
IIIrem Ilgezdi
Irem Ilgezdi
UMUmmu Mutlu
Ummu Mutlu
AOAli Emre Oge
Ali Emre Oge
Motor unit number estimation (MUNE) methods including the one using F-waves (F-MUNE) are used to detect axonal loss in polyneuropathies. The aim of this study is to evaluate the amount of axonal loss by repeater F-wave parameters and F-MUNE in patients with type 2 diabetes mellitus (DM). In 24 controls and 49 patients with diabetic polyneuropathy, 90 F-waves elicited with supramaximal and 300 F-waves with submaximal stimulation of the ulnar nerve were recorded from the abductor digiti minimi muscle. F-MUNE values were calculated using the automated software with the repeater F-waves elicited using submaximal stimulation. Ulnar repeater F-wave index and repeater neuron index were found to be significantly higher in patients with DM compared with the control group. The amplitudes of F-waves elicited using both sub- and supramaximal stimulus intensities were reduced in patients with polyneuropathy when compared with controls. The F-MUNE values were found to be similar between the two groups. Repeater F-wave parameters recorded from the upper extremity might indicate the presence of axon loss in DM-related polyneuropathy. However, F-MUNE failed to reveal axonal loss in diabetic polyneuropathy probably because of its length-dependent nature and the dominance of low-amplitude F-waves, which might be secondary to several yet unknown mechanisms, mainly related to sensory fiber dysfunction.

1 January 2025 in Dusunen Adam: Journal of Psychiatry and Neurological Sciences
Verified
Journal Article
Open access
PDF file
IGIsil Yazici Gencdal
Isil Yazici Gencdal
MKMesrure Koseoglu
Mesrure Koseoglu
VKVasfiye Kabeloglu
Vasfiye Kabeloglu
KBKursad Nuri Baydili
Kursad Nuri Baydili
Objective: Obstructive sleep apnea syndrome (OSAS) significantly impairs the quality of life of affected individuals. This study aimed to assess the health-related quality of life (HRQoL) among patients with mild, moderate, and severe OSAS, and to evaluate differences in HRQoL following a minimum of three months of continuous positive airway pressure (CPAP) therapy. Method: Subjective daytime sleepiness and HRQoL were assessed using standardized questionnaires, including the Epworth Sleepiness Scale (ESS), Fatigue Severity Scale (FSS), Beck Depression Inventory (BDI), Apathy Evaluation Scale (AES), and Montgomery-Åsberg Depression Rating Scale (MADRS). Assessments were conducted at the initial visit following an OSAS diagnosis, confirmed through clinical and polysomnographic evaluation. After at least three months of CPAP therapy, the same HRQoL questionnaires were re-administered. The percentage change difference (PCD) for each questionnaire was calculated by comparing baseline scores with those obtained after at least three months of CPAP therapy. Results: A total of 87 patients with OSAS were included in the study. Twenty-seven were female (31%) and 60 were male (69%). Comparison of scale scores before and after CPAP therapy revealed statistically significant reductions across the ESS, BDI, AES, MADRS, and FSS questionnaires (p<0.001). A weak positive correlation was found between the ESS PCD and body mass index, while a moderate negative correlation was observed between the AES PCD and duration of CPAP therapy (p<0.001). Conclusion: Significant improvements in HRQoL were observed following CPAP therapy, regardless of disease severity, gender, presence of comorbid conditions, and smoking status. With the exception of AES scores, these improvements were also independent of the duration of CPAP therapy. Among the HRQoL scales, only AES scores showed a statistically significant reduction after more than six months of CPAP therapy.

20 June 2025 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
IGIşil Yazici Gençdal
Işil Yazici Gençdal
NŞNermi̇n Görkem Şi̇rİn
Nermi̇n Görkem Şi̇rİn
IIİrEm İlGezdi̇
İrEm İlGezdi̇
ÜMÜmmü Mutlu
Ümmü Mutlu
EOEli̇f Kocasoy Orhan
Eli̇f Kocasoy Orhan
AÖAli̇ Emre Öge
Ali̇ Emre Öge
Background/aim: To investigate the diagnostic sensitivity of sural sensory nerve action potential (SNAP) to medial femoral cutaneous nerve and dorsal sural to sural SNAP amplitude ratios in patients with diabetic polyneuropathy. Materials and methods: Sural/radial (SRAR), sural/medial femoral cutaneous (SMFAR), and dorsal sural/sural (DSSAR) SNAP amplitude ratios were calculated in 22 controls and 46 patients with type 2 diabetes mellitus. Combined sensory scores (superficial peroneal, sural, dorsal sural, and medial plantar SNAPs), and amplitude ratio scores (SRAR, DSSAR, and SMFAR) were assessed. The parameters were compared statistically between the patient and control groups. Results: All SNAP amplitudes were significantly lower in patients as compared with those of the controls. Reduced medial plantar SNAP amplitude was the most frequent abnormality in the patient group. DSSAR and SMFAR, but not SRAR were found to have significant value in differentiating patients from controls with low sensitivity and moderate specificity. The combined sensory score improved the diagnostic accuracy for diabetic polyneuropathy, while the other combined scores add no additional value in this respect. Conclusion: Distal nerve conduction studies (NCSs) are most useful in diagnosing mild diabetic polyneuropathy. Although DSSAR and SMFAR can be moderately sensitive alternatives, particularly when used in combined scores, these ratios do not add any diagnosticvalue in patients with axonal polyneuropathies of similar severity.